Influence of Oral Messages on the Activity of Wrist and Finger Flexor Muscles

August 8, 2022 updated by: Kamil Zaworski, John Paul II University of Applied Sciences in Biala Podlaska

Influence of Oral Messages on the Activity of Wrist and Finger Flexor Muscles - in the Context of Application of Sham Therapy

The aim of the study will be to evaluate the effect of oral messages on wrist and finger flexor muscle activity during the application of sham therapy in the form of paper plaster.

For years, research has been conducted on the effects of dynamic plaster and rigid plaster on muscle function. In many cases, reports from different authors are contradictory. Therefore, the planned study will use placebo paper plaster with no proven therapeutic effect.

Study Overview

Detailed Description

People's words can have a huge impact on how we interpret our surroundings, what we expect and experience, and how we behave. The placebo (and nocebo) effects are a clear example here. The way health professionals discuss, describe and inform patients about the characteristic effects of a given disease, its prevention, diagnosis and treatment influences patients' feelings and expectations, which in turn affects their psychobiological responses, subjective feelings and treatment outcomes.

The right choice of words by clinicians influences patients' response to medical treatments and procedures, both active and sham. The way in which information about the effects of treatment is communicated to patients can reinforce the outcomes of a particular treatment (placebo) or reverse clinically-proven effects of an active treatment, or even increase its adverse effects. The right messages can reduce the nocebo effect. And vice versa, the wrong choice of information provided may increase the patient's anxiety and disease symptoms.

The aim of the study will be to evaluate the effect of oral messages on wrist and finger flexor muscle activity during the application of sham therapy in the form of paper plaster.

Main hypothesis:

The use of a positive message will have an effect on increasing the activation and strength of the flexor muscles of the wrist joint and fingers.

Research questions:

  1. Does a positive message have an effect on increasing the activation and strength of the flexor muscles of the wrist joint and fingers?
  2. Does a negative message have an effect on increasing the activation and strength of the flexor muscles of the wrist joint and fingers? Does a neutral message have an effect on increasing the activation and strength of the flexor muscles of the wrist joint and fingers?

The study will be a prospective, flow-up study using a differential variable in the form of the type of message used (positive - placebo, negative - nocebo, neutral). The respondents will be randomly allocated to study groups using sealed allocation sheets.

Before taking part in the study, each subject will be familiarised with the course of the study and must give written informed consent to participate in the study and to be randomly assigned to a specific study group.

The subjects will be assessed twice - before applying a paper plaster and 10 minutes after applying the plaster and delivering a voice message.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Biała Podlaska, Poland, 21-500
        • Pope John Paul II State School Of Higher Education in Biała Podlaska

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 24 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • subjects not using non-steroidal anti-inflammatory drugs (NSAIDs) for at least one week prior to study entry,
  • age - 19-24 years,
  • written consent to participate in the study.

Exclusion Criteria:

  • subjects studying for a degree in physiotherapy,
  • subjects post surgery on the examined upper limb,
  • subjects with past bone fractures in the examined upper limb,
  • subjects who have had an injury to the examined upper limb within 6 months before the start of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Positive message
Group A - 30 subjects who will be told that positive message.
Subjects who will be told that "the applied plastering method significantly increases muscle strength" (positive message - placebo).
Experimental: Negative message
Group B - 30 subjects who will be told negative message.
Subjects who will be told that "the applied plastering method has no effect on muscle strength" (negative message - nocebo).
Experimental: Neutral message
Group C - 30 people who will be told neutral message.
Subjects who will be told that "the applied plastering method is currently under investigation and the investigators do not know its effects" (neutral message).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dynamometer tests
Time Frame: Change in measured parameters 10 minutes after application of the plaster and delivery of the oral message relative to baseline measurement.
Assessment of wrist and finger flexor muscle strength. Patient in sitting position with the elbow joint on the examined side bent and the forearm resting on the table. The patient squeezes the dynamometer for a period of 3-5 seconds.
Change in measured parameters 10 minutes after application of the plaster and delivery of the oral message relative to baseline measurement.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Testing with Naroxon Ultimum EMG
Time Frame: Change in measured parameters 10 minutes after application of the plaster and delivery of the oral message relative to baseline measurement.

Assessment of wrist and finger flexor muscle activity. Patient in sitting position with the elbow joint on the examined side bent and the forearm resting on the table. The subject's arm is adducted, the wrist joint in an intermediate position. The electrodes are glued in the belly area of the flexor muscles of the wrist and fingers - about 2 cm from the medial epicondyle of the humerus in a distal direction at a distance of 1 cm from each other.

The patient squeezes the dynamometer for a period of 3-5 seconds.

Change in measured parameters 10 minutes after application of the plaster and delivery of the oral message relative to baseline measurement.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Kamil Zaworski, FIZJOPERFEKT Kamil Zaworski

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2021

Primary Completion (Actual)

April 30, 2022

Study Completion (Actual)

August 8, 2022

Study Registration Dates

First Submitted

December 28, 2021

First Submitted That Met QC Criteria

January 11, 2022

First Posted (Actual)

January 25, 2022

Study Record Updates

Last Update Posted (Actual)

August 10, 2022

Last Update Submitted That Met QC Criteria

August 8, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PopeJohnPaulIIStateSchHigherE3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Communication

Clinical Trials on Positive message - placebo

Subscribe